L&C BIO Co.,LTD
Research L&C BIO Co.,LTD (290650.KQ) on Bullrun: market cap KRW 1.94T, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker290650.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 1.94T
- Dividend yield0.1%
- Financial periodQ2 2026
- RevenueKRW 38.79B
- Net income-KRW 28.00B
- Free cash flow-KRW 7.16B
- Gross margin60.9%
Valuation Snapshot
latest market cap is KRW 1.94T; dividend yield is 0.1%.
Peer valuation comparison
Latest dividend yield is 0.07% versus a Healthcare sector median of 2.4% (97.1% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 1.94T | n/a | 0.1% | 48.35 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 48.35 KRW, yield 0.1%.
About L&C BIO Co.,LTD
L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is L&C BIO Co.,LTD's market cap?
L&C BIO Co.,LTD's market capitalization is KRW 1.94T.
Does L&C BIO Co.,LTD pay a dividend?
L&C BIO Co.,LTD has a dividend yield of 0.1%.
What does L&C BIO Co.,LTD do?
L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.